Replacement: Sale of Kirkstall and CLN

Summary by AI BETAClose X

Truetide PLC has announced the sale of its 86.11% shareholding in Kirkstall Limited to Imaging Biometrics Limited (IBAI) for a total consideration of £146,421.41, equivalent to £0.015717 per Kirkstall share. The consideration will be satisfied by the issuance of an unsecured Convertible Loan Note (CLN) by IBAI to Truetide. The CLN has a principal value of £170,000, with £146,421.41 covering the consideration and £23,578.59 subscribed for in cash, bearing interest at 6% per annum. The CLN can be converted into IBAI Ordinary Shares at £0.0075 or the subscription price of any fundraising before conversion, with a final redemption date of December 31, 2027. Kirkstall had a loss of £4,091 and net assets of -£116,185 in the year ended March 31, 2025.

Disclaimer*

UK 100

Latest directors dealings